Log in to search using one of your social media accounts:

This page shows you the latest news items in this category.

Regeneron and Sanofi Announce Kevzara(R) (sarilumab) Biologics License Application Resubmission Accepted for Review by U.S. FDA
New action date for Kevzara U.S. BLA is May 22, 2017 TARRYTOWN, N.Y. and PARIS, April 28, 2017 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administra... Biopharmaceuticals Regeneron Pharmaceuticals, Sanofi, Kevzara, sarilumab, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 28, 2017 Category: Pharmaceuticals Source Type: news

TfL launches badge to recognise customers with invisible impairments
(Source: TfL)Transport for London (TfL) has launched a‘Please offer me a seat’ badge to recognise customers with invisible impairments.The‘Please Offer Me a Seat’ badge and card was created following requests from customers, particularly those with invisible impairments, conditions and illnesses, who struggle to get a seat as their need for one isn’t immediately obvious.A six-week trial with 1,200 users was held in autumn last year to test if the badge and card would help people getting a seat. Over the course of the trial, participants’ confidence in using the network increased. More th...
Source: Arthritis Research UK - April 27, 2017 Category: Rheumatology Source Type: news

Phoenix Food, LLC Announces Voluntary Recall Of Dip Trio Mix Due To Possible Health Risk
Phoenix Food, LLC (the company) of Canton, Texas announced it is voluntarily recalling select Dip Trio Mixes due to the potential presence of Salmonella in the seasoning packet. Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as art...
Source: Food and Drug Administration - April 27, 2017 Category: Food Science Source Type: news

Stem cells edited to fight arthritis
Using CRISPR technology, a team of researchers rewired stem cells ' genetic circuits to produce an anti-inflammatory arthritis drug when the cells encounter inflammation. The technique eventually could act as a vaccine for arthritis and other chronic conditions. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 27, 2017 Category: Science Source Type: news

Helping juvenile idiopathic arthritis sufferers
A drug combination that could help thousands of children with arthritis has been discovered by a team of researchers. Children and adolescents with Juvenile Idiopathic Arthritis (JIA) are likely to develop uveitis, a condition that causes inflammation in the middle layer of the eye. The drug combination discovery will help preventing them from serious complications, including blindness. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 27, 2017 Category: Science Source Type: news

Arthritis news: Condition can cause BLINDNESS in sufferers
ARTHRITIS can trigger loss of sight in sufferers - known as uveitis - but scientists have just discovered a drug to stop sufferers developing blindness. (Source: Daily Express - Health)
Source: Daily Express - Health - April 27, 2017 Category: Consumer Health News Source Type: news

Women More Sensitive to Metal Joint Implants Than Men: Study
Title: Women More Sensitive to Metal Joint Implants Than Men: StudyCategory: Health NewsCreated: 4/26/2017 12:00:00 AMLast Editorial Review: 4/27/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - April 27, 2017 Category: Rheumatology Source Type: news

Clinical trial discovers a new way to prevent children with arthritis and eye disease losing their sight
This study demonstrates the benefit of adalimumab in children with uveitis. This is the first randomised trial of its kind worldwide and the results will have a major impact in children with uveitis all around the world."Finding the best way of caring for children with arthritis and uveitisProfessor Beresford from University of Liverpool and Alder Hey Children’s NHS Foundation Trust said: "This landmark trial has demonstrated the commitment and leadership of colleagues across the UK in working closely with patients and parents in tackling a key priority of finding the very best way of caring for children with arthrit...
Source: Arthritis Research UK - April 26, 2017 Category: Rheumatology Source Type: news

Can-Fite to begin Phase III trial of piclidenoson in Israel to treat rheumatoid arthritis
Biotechnology company Can-Fite BioPharma has obtained approval from the Institutional Review Board (IRB) of Barzilai Medical Center in Israel, to begin patient enrolment in the Phase III ACRobat clinical trial of piclidenoson for the treatment of rhe … (Source: Drug Development Technology)
Source: Drug Development Technology - April 26, 2017 Category: Pharmaceuticals Source Type: news

Women of South Asian descent 'may be at greater risk of osteoporosis'
This study focused on trends in bone resorption, the process by which bone tissue is broken down by osteoclast cells to enable the transfer of calcium from bone tissue into the bloodstream. This is an essential function that help to body adapt to change and repair damage, but when it becomes excessive and unbalanced, it can be detrimental to bone health. Researchers examined 370 pre and postmenopausal South Asian and white Caucasian women in the UK over a 12-month period by measuring levels of N terminal telopeptide, a byproduct of bone resorption found in urine. It was found that premenopausal South Asian women had higher...
Source: Arthritis Research UK - April 26, 2017 Category: Rheumatology Source Type: news

Cost controls help offset lower Amgen first-quarter drug sales
(Reuters) - Amgen Inc on Wednesday reported higher-than-expected first-quarter profit as cost controls helped offset a sharp drop in sales of Enbrel, its blockbuster rheumatoid arthritis and psoriasis drug. (Source: Reuters: Health)
Source: Reuters: Health - April 26, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Approves XATMEP(TM), the First and Only Ready-To-Use Methotrexate Oral Solution
DENVER, April 26, 2017 -- (Healthcare Sales & Marketing Network) -- Silvergate Pharmaceuticals, Inc. (www.silvergatepharma.com), leaders in the development and commercialization of innovative and safe medicines for children, today announced that the Unite... Biopharmaceuticals, FDA Silvergate Pharmaceuticals, XATMEP, methotrexate, arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 26, 2017 Category: Pharmaceuticals Source Type: news

Early Treatment Equals Better Results for Rheumatoid Arthritis
Title: Early Treatment Equals Better Results for Rheumatoid ArthritisCategory: Health NewsCreated: 4/25/2017 12:00:00 AMLast Editorial Review: 4/26/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - April 26, 2017 Category: Rheumatology Source Type: news

Early Treatment Equals Better Results for Rheumatoid Arthritis
Study found less disability, lower risk of early deathSource: HealthDay Related MedlinePlus Pages: Autoimmune Diseases, Rheumatoid Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 25, 2017 Category: Consumer Health News Source Type: news

Arthritis cure: Would you use THIS extreme treatment to ease the pain?
ARTHRITIS can cause bouts of joint pain, sometimes leaving sufferers immobile and depressed - but this man has an unusual solution to his. (Source: Daily Express - Health)
Source: Daily Express - Health - April 25, 2017 Category: Consumer Health News Source Type: news

Eli Lilly ’ s diabetes drugs boost Q1 revenue, earnings
Shares in Eli Lilly (NYSE:LLY) fell slightly today as the company met expectations on Wall Street with its 1st quarter financial results. The company has faced its share of issues in the last year – Lilly took a $150 million hit in November after its Alzheimer’s drug failed in a clinical trial and this month, the FDA rejected its rheumatoid arthritis drug. But the company’s diabetes therapies, such as Trulicity and Humalog, helped to propel the company to an adjusted quarterly profit that beat expectations on The Street. “We are encouraged by another solid performance from Lilly’s overall di...
Source: Mass Device - April 25, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Diabetes MassDevice Earnings Roundup Pharmaceuticals Wall Street Beat Eli Lilly & Co. Source Type: news

Early Treatment Equals Better Results for Rheumatoid Arthritis
TUESDAY, April 25, 2017 -- Treating rheumatoid arthritis early may make for better outcomes, a new study suggests. Patients who were treated within six months of developing the first signs of the autoimmune disease did better in the long run and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 25, 2017 Category: Journals (General) Source Type: news

Sanofi and Regeneron ’s Kevzara receives CHMP opinion to treat Rheumatoid Arthritis
Regeneron Pharmaceuticals and Sanofi ’s Kevzara (sarilumab) has received a positive opinion from the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) to treat adult patients with moderately to severely active rheu… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 24, 2017 Category: Pharmaceuticals Source Type: news

Rheumatoid arthritis patients 'at an increased risk of atherosclerosis'
This study confirms increased prevalence of atherosclerosis in rheumatoid arthritis and provides data to support the hypothesis that patients have a high-risk plaque phenotype." Arthritis Research UK's view Dr Natalie Carter, head of research liaison and evaluation at Arthritis Research UK, said:"Rheumatoid arthritis is an incredibly debilitating condition that affects more than 400,000 people within the UK. The condition can not only limit a person's ability to live their everyday life to the full, but it can also put them at higher risk of cardiovascular disease. "This study not only reinforces the...
Source: Arthritis Research UK - April 24, 2017 Category: Rheumatology Source Type: news

Early Treatment Boosts Long-term Rheumatoid Arthritis Outcomes Early Treatment Boosts Long-term Rheumatoid Arthritis Outcomes
Early treatment boosts long-term arthritis outcomes and may be contributing to lower arthritis-related mortality, two new studies suggested.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 24, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara(R) (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis
TARRYTOWN, N.Y. and PARIS, April 24, 2017 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP... Biopharmaceuticals, Regulatory Regeneron Pharmaceuticals, Sanofi, Kevzara, sarilumab, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2017 Category: Pharmaceuticals Source Type: news

Early Treatment Boosts Long-Term Arthritis Outcome
Early Treatment Boosts Long-Term Rheumatoid Arthritis Outcomes (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 24, 2017 Category: Journals (General) Source Type: news

2017 Annual Fellows' Meeting Report
The 2017 Annual Fellows' Meeting was held on 30th-31st March, and highlighted the prominent and innovative research currently ongoing by our fellows and PhD students.Day 1Jane Worthington, Chair of the newly established Fellowship Expert Group, opened the meeting with an enthusiastic introduction to the packed agenda for the two days, highlighting the opportunity for networking, the two keynote speakers and chance to hear the excellent research endeavours of the current cadre Arthritis Research UK fellows.The floor was then open for our fellows to present their research, with the first series of research presentations gene...
Source: Arthritis Research UK - April 23, 2017 Category: Rheumatology Source Type: news

Diets high in fat and carbohydrates 'may lead to osteoarthritis'
This study supports our advice that a diet that is low in saturated fats can help the ten million people in the UK who have arthritis. We also know that vitamins and minerals such as calcium, vitamin D and iron are important for maintaining healthy joints and bones. "Being overweight puts more strain on joints, which can affect the likelihood of developing arthritis. Losing weight may mean a person doesn't have to takepainkillers so often." (Source: Arthritis Research UK)
Source: Arthritis Research UK - April 23, 2017 Category: Rheumatology Source Type: news

Surgeons injecting Botox into arthritis patients
British surgeons are injecting the toxin, loved by celebrities and millions of Britons for its ability to reduce lines in the face, into the shoulders of patients with rotator cuff arthropathy. (Source: the Mail online | Health)
Source: the Mail online | Health - April 22, 2017 Category: Consumer Health News Source Type: news

MATT ROBERTS: Saddle up... and cycle away arthritus pain  
MATT ROBERTS on cycling to beat the pain of arthritis, the best exercises for slimming down when you are over 50 and how important it is for our politicians to be fit. (Source: the Mail online | Health)
Source: the Mail online | Health - April 22, 2017 Category: Consumer Health News Source Type: news

FDA approves Samsung Bioepis' copy of J & J's Remicade: company
SEOUL (Reuters) - South Korea's Samsung Bioepis Co Ltd said on Saturday the U.S. Food and Drug Administration approved its copy of Johnson& Johnson's rheumatoid arthritis drug Remicade, the first drug developed by the Samsung Group unit approved in the United States. (Source: Reuters: Health)
Source: Reuters: Health - April 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

EU Regulators OK Sarilumab (Kevzara) for Rheumatoid Arthritis EU Regulators OK Sarilumab (Kevzara) for Rheumatoid Arthritis
A committee of the European Medicines Agency also recommended approval of Erelzi, a biosimilar to entanercept that treats six different inflammatory disorders.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 21, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

FDA approves 2nd near-copy of Remicade for immune disorders
Federal regulators have approved another alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders (Source: ABC News: Health)
Source: ABC News: Health - April 21, 2017 Category: Consumer Health News Tags: Health Source Type: news

EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
(Reuters) - A European Medicines Agency panel said on Friday it recommended granting marketing approval to Sanofi and Regeneron's experimental drug to treat rheumatoid arthritis. (Source: Reuters: Health)
Source: Reuters: Health - April 21, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Arthritis symptoms: Seven signs YOU could be suffering with painful condition
ARTHRITIS is a painful condition affecting ten million people – young as well as old. Signs and symptoms you should look out for explained. (Source: Daily Express - Health)
Source: Daily Express - Health - April 21, 2017 Category: Consumer Health News Source Type: news

Patient-Reported Outcomes and MRI Measures in RA Patient-Reported Outcomes and MRI Measures in RA
Are MRI measures associated with patient-reported outcomes among those with rheumatoid arthritis?Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 21, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Health Tip: Dealing With Foot Arthritis
-- Just about everyone has occasional foot pain, but persistent symptoms may signal foot arthritis. The American Podiatric Medical Association suggests seeing a doctor about: Having swelling that affects one or more joints. Having ongoing... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 21, 2017 Category: Journals (General) Source Type: news

Health Tip: Dealing With Foot Arthritis
Title: Health Tip: Dealing With Foot ArthritisCategory: Health NewsCreated: 4/21/2017 12:00:00 AMLast Editorial Review: 4/21/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - April 21, 2017 Category: Rheumatology Source Type: news

Workshop on patient involvement and communication
Our strategic focus to 2020 is to put people with arthritis at the heart of everything we do. This includes listening to, and involving, them in all aspects of our work. As such, the perspectives and insights of people with arthritis are essential in the review of funding applications. People with arthritis ensure that the research we fund is the most relevant to them.We advocate this same approach to our funded researchers and those applying to us for funding. We ask all applicants to demonstrate how they have engaged and/or involved people with arthritis in the development of their proposal and how they will do so if awa...
Source: Arthritis Research UK - April 20, 2017 Category: Rheumatology Source Type: news

FDA clears Halyard ’ s Coolief RF device for treating OA pain
Halyard Health (NYSE:HYH) said today it won FDA clearance for its Coolief cooled radiofrequency thermal system designed for treating moderate to severe chronic osteoarthritis knee pain The Alpharetta, Ga.-based company claims that the Coolief is the 1st and only RF treatment to be cleared by the FDA for relieving OA pain. “I see many patients who suffer with chronic osteoarthritis knee pain in my practice who are not immediate candidates for knee replacement surgery due to co-morbidities, such as obesity or other chronic health issues. Coolief Cooled RF treatment provides significant pain relief for patients wit...
Source: Mass Device - April 20, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Orthopedics Pain Management Regulatory/Compliance Halyard Health Source Type: news

Studies examine rheumatoid arthritis patients' prognosis
(Wiley) What's the long-term outlook for today's patients with early rheumatoid arthritis? A new study in Arthritis& Rheumatology that looks at patients' mortality, disease activity, and physical function over the course of 20 years reveals the importance of early treatment. Another study in the journal notes that deaths from arthritis are declining. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 20, 2017 Category: Global & Universal Source Type: news

Rheumatoid arthritis medications: Dangerous during pregnancy?
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - April 20, 2017 Category: Consumer Health News Source Type: news

Opioid Use Common Even After Minor Surgery
This study shows that new chronic opioid use after surgery may be one of the most common complications after surgery,” said lead study author Dr. Chad Brummett of the University of Michigan in Ann Arbor. “Given that the rates of new chronic use did not differ between major and minor surgery, this suggests that patients continue to use their opioids for reasons other than the pain from the surgery,” Brummett added by email. Addressing patients’ acute pain during their recovery from surgery may be a way to prevent them from becoming a statistic in the opioid epidemic, he suggested. About 50 million pe...
Source: Healthy Living - The Huffington Post - April 19, 2017 Category: Consumer Health News Source Type: news

Rheumatoid arthritis cure: Symptoms halted by doing THIS (it could prevent joint damage)
RHEUMATOID ARTHRITIS sufferers have been sent a lifeline thanks to a new study which found early treatment can reduce symptoms for years afterwards. (Source: Daily Express - Health)
Source: Daily Express - Health - April 19, 2017 Category: Consumer Health News Source Type: news

Investors bet on Incyte cancer drug success
Immunotherapy hopes push up shares 60% despite arthritis treatment knock-back (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 19, 2017 Category: Pharmaceuticals Source Type: news

La Granja INC. Recalls Mango Flavored Ice cream Because of Possible Health Risk
La Granja INC of Doraville Georgia is recalling 4000 units of Hand crafted Paleteria, Mango Flavored Ice cream, because it has the potential to be contaminated with Salmonella Enteritidis, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy individuals may suffer only short-term symptoms pain and diarrhea. Long term complications can include severe arthritis. (Source: Food and Drug Administration)
Source: Food and Drug Administration - April 19, 2017 Category: Food Science Source Type: news

Rheumatoid arthritis patients 'have experienced progress in recent decades'
This study confirms how important early diagnosis and the commencement of treatment is. It is also encouraging to hear about the progress that has been made over the last 20 years. "Now the scientific community must continue to build on this, so that together we can continue to harness the power of exceptional science and make everyday life better for all people with arthritis." (Source: Arthritis Research UK)
Source: Arthritis Research UK - April 18, 2017 Category: Rheumatology Source Type: news

A high-fat, high-carb diet can cause arthritis
Research suggests junk food may weaken joints, leading to osteoarthritis, according to researchers from Queensland University of Technology's Institute of Health and Biomedical Innovation. (Source: the Mail online | Health)
Source: the Mail online | Health - April 18, 2017 Category: Consumer Health News Source Type: news

RA Patients May Benefit From Using a Pedometer RA Patients May Benefit From Using a Pedometer
Patients with rheumatoid arthritis (RA) who receive pedometers may be more active and feel less fatigued even if they are not told to use the trackers to aim for a specific number of steps, a small study suggests.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - April 18, 2017 Category: Orthopaedics Tags: Rheumatology News Source Type: news

Medical News Today: Osteoarthritis linked to high-fat diet
A new study demonstrates a connection between osteoarthritis and a high-fat, high-carbohydrate diet. Coconut oil, however, may have a protective effect. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 18, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Medical News Today: Diet tips for psoriatic arthritis: Foods to eat and avoid
In this article, learn about the foods to eat for people with psoriatic arthritis. Also find how to maintain a healthy gut including the use of probiotics. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 18, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Arthritis warning: Eating THESE types of food can 'lead to joint problems'
EATING high-fat, high-carb meals like fish and chips or doner kebabs can lead to joint problems and arthritis, according to new research. (Source: Daily Express - Health)
Source: Daily Express - Health - April 18, 2017 Category: Consumer Health News Source Type: news

US FDA declines approval of Eli Lilly and Incyte ’s baricitinib drug to treat RA
Eli Lilly and partner Incyte have announced that the US Food and Drug Administration (FDA) has declined to approve a new drug, baricitinib, to treat moderate-to-severe rheumatoid arthritis (RA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 17, 2017 Category: Pharmaceuticals Source Type: news